Biosimilars in rheumatology: what the clinician should know
Biosimilars are now a reality in rheumatology. Although analytical and non-clinical procedures to establish similarity have evolved significantly, clinical trials demonstrating equivalent efficacy and safety are absolutely required for all biosimilars. The design of such trials, including equivalenc...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015-08-01
|
| Colecção: | RMD Open |
| Acesso em linha: | https://rmdopen.bmj.com/content/1/1/e000010.full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|